AccuStem Sciences Limited

ACMSY · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$332-$470-$440-$2,032
Dep. & Amort.$1-$0$0$5
Deferred Tax$0$0$0$0
Stock-Based Comp.-$124$92$18$88
Change in WC-$452-$119$0$595
Other Non-Cash$304$228$131$1,108
Operating Cash Flow-$604-$269-$290-$237
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0-$350
Dividends Paid$0$0$0$0
Other Fin. Act.$587$327$322-$157
Financing Cash Flow$587$327$322-$157
Forex Effect$0$0$0$0
Net Chg. in Cash-$17$26$31-$32
Supplemental Information
Beg. Cash$31$5$5$37
End Cash$14$31$36$5
Free Cash Flow-$604-$269-$290-$237
AccuStem Sciences Limited (ACMSY) Financial Statements & Key Stats | AlphaPilot